Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
The Beachbody Company, a Leader in Digital Fitness Streaming and Nutrition Solutions, to Become Publicly Traded Company
-
Forest Road Acquisition Corp. (FRX) Prices 26.1M Unit Upsized IPO $10/Unit
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
-
Fennec Announces Closing of Public Offering
-
Fennec Pharmaceuticals (FENC) Prices 4.8M Common Stock Offering at $6.25/Share
-
Fennec Announces Pricing of Public Offering
-
Fennec Pharmaceuticals (FENC) Announces Proposed Public Offering of Common Shares
-
Fennec Announces Proposed Public Offering of Common Shares
-
Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
-
Fennec to Present at Cantor Fitzgerald Global Healthcare Conference on October 1, 2018 in New York City
-
Fennec to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 in New York City
-
Fennec to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference in New York on July 13, 2016
-
Streetinsider.com's Hot Lunchtime Reads 02/18: (LVS) (MSFT) (SWY) (SNI)
-
Cantor Fitzgerald Downgrades Forest Laboratories (FRX) to Hold (IRWD)
-
Pre-Open Stock Movers 2/18: (FRX) (VDSI) (ACT) Higher; (LIVE) (WM) (KO) Lower (more...)
-
Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)
-
Cantor Fitzgerald's Conviction Calls For 2013
-
Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Shares Still Overvalued
-
Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official
-
Cantor Fitzgerald Maintains a 'Buy' on Forest Laboratories (FRX); Raising PT and Estimates
-
Cantor Fitzgerald Raises Price Target on Forest Laboratories (FRX) on Q3 Upside and New FY12 Guidance
-
Cantor Fitzgerald Starts Forest Laboratories (FRX) at Buy; Can Forest Find Its Roots?
-
Notable Analyst Rating Changes 10/07: NOK, ALU, FCX, TU Upgraded; FSLR, SPWR, DIS, IBM, FRX Downgraded

